Trademark: 90327954
Status Date
Wednesday, June 8, 2022
Filing Date
Wednesday, November 18, 2020
Abandoned Date
Tuesday, May 24, 2022
5 Pharmaceutical preparations for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders, namely, COVID-19/Coronavirus; Pharmaceutical preparations for the treatment of COVID-19/Coronavirus; Intranasal pharmaceutical solutions for use as a neutralizing antibody against COVID-19/Coronavirus
Jun 9, 2022
Abandonment Notice Mailed - Incomplete Response
Jun 8, 2022
Abandonment Notice Mailed - Incomplete Response
Jun 8, 2022
Abandonment - Incomplete Response
May 27, 2022
Teas/Email Correspondence Entered
May 23, 2022
Correspondence Received In Law Office
May 23, 2022
Teas Request For Reconsideration Received
Nov 23, 2021
Notification Of Final Refusal Emailed
Nov 23, 2021
Final Refusal E-Mailed
Nov 23, 2021
Final Refusal Written
Oct 21, 2021
Teas/Email Correspondence Entered
Oct 20, 2021
Correspondence Received In Law Office
Oct 20, 2021
Teas Response To Office Action Received
Apr 21, 2021
Notification Of Non-Final Action E-Mailed
Apr 21, 2021
Non-Final Action E-Mailed
Apr 21, 2021
Non-Final Action Written
Apr 8, 2021
Assigned To Examiner
Jan 25, 2021
New Application Office Supplied Data Entered In Tram
Nov 21, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
